Schaller-Paule, Martin A. http://orcid.org/0000-0003-1447-9908
Maiworm, Michelle
Schäfer, Jan Hendrik
Friedauer, Lucie
Hattingen, Elke
Wenger, Katharina Johanna
Weber, Frank
Jakob, Jasmin
Steffen, Falk
Bittner, Stefan
Yalachkov, Yavor
Foerch, Christian
Funding for this research was provided by:
Sanofi Genzyme (GZ-2016-11612)
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 26 October 2023
Revised: 15 February 2024
Accepted: 4 March 2024
First Online: 27 March 2024
Declarations
:
: The authors MSP, MM, JHS, FS, LF, JJ, KW, EH, and WM declare that there is no conflict of interest to report. CF reports speaker honoraria and honoraria for participating on advisory boards from Novartis, Teva, Merck, Sanofi Genzyme, Alexion, Bristol-Myers Squibb, and Roche, and has received research support from Sanofi Genzyme and Novartis. S.B. has received honoraria from Biogen Idec, Bristol Meyer Squibbs, Hexal, Merck Healthcare, Mylan, Novartis, Roche, Sanofi Genzyme and TEVA. Yavor Yalachkov has received speaking/writing/advisory board honoraria, compensation for chairman activity and travel grants from Bristol Meyers Squibb, Novartis, Merck, Roche, RG Gesellschaft für Information und Organisation mbH, Sanofi Genzyme, TEVA. His research is supported by the Heinrich und Erna Schaufler-Stiftung as well as the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG).
: All human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All patients gave their informed consent prior to their inclusion in the study.